[{"AccountsPayableCurrent_0_Q1_USD":4634791.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":2539565.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-3500955.0,"NetIncomeLoss_1_Q1_USD":-10882367.0,"NonoperatingIncomeExpense_1_Q1_USD":871003.0,"OperatingExpenses_1_Q1_USD":11723390.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":2195690.0,"PaymentsOfFinancingCosts_1_Q1_USD":146717.0,"PensionContributions_1_Q1_USD":22682.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"PreferredStockValue_0_Q1_USD":null,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":377860.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":2312785.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":373497.0,"ProfitLoss_1_Q1_USD":-10882367.0,"ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned_1_Q1_USD":810730.0,"ResearchAndDevelopmentExpense_1_Q1_USD":8656439.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-208468231.0,"ShareBasedCompensation_1_Q1_USD":3908771.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_1_Q1_USD":2.85,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q1_pure":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q1_pure":0.9679,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q1_pure":0.0137,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q1_shares":160000.0,"StockholdersEquity_0_Q1_USD":146367706.0,"LiabilitiesCurrent_0_Q1_USD":10528662.0,"StockIssuedDuringPeriodValueOther_1_Q1_USD":2149701.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":156896368.0,"InterestIncomeExpenseNet_1_Q1_USD":4910.0,"AccruedBonusesCurrent_0_Q1_USD":1205186.0,"AccruedLiabilitiesCurrent_0_Q1_USD":5450040.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":354759781.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":3908771.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":11403769.0,"Assets_0_Q1_USD":156896368.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":151146355.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1_Q1_USD":-961390.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"CommonStockSharesAuthorized_0_Q1_shares":200000000.0,"CommonStockSharesIssued_0_Q1_shares":76155187.0,"CommonStockSharesOutstanding_0_Q1_shares":76155187.0,"CommonStockValue_0_Q1_USD":76156.0,"CurrentIncomeTaxExpenseBenefit_1_Q1_USD":29980.0,"DeferredIncomeCurrent_0_Q1_USD":443831.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.14,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q1_USD":18170000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q1_USD":55363.0,"GeneralAndAdministrativeExpense_1_Q1_USD":3066951.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-10852387.0,"IncomeTaxesReceivable_0_Q1_USD":5372153.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-104992.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-164734.0,"IncreaseDecreaseInIncomeTaxesReceivable_1_Q1_USD":-3764678.0,"IncreaseDecreaseInPrepaidExpense_1_Q1_USD":22311.0,"LeaseAndRentalExpense_1_Q1_USD":4845.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":75997738.0,"Ticker":"AVXL","CIK":"1314052","name":"ANAVEX LIFE SCIENCES CORP.","OfficialName":"Anavex Life Sciences Corp. Common Stock","form":"10-Q","period":"20211231","fy":"2022.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"825317693.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20220209"}]